Special Agent Douglas Loveland of the Office of Criminal Investigation for the FDA discusses why they need to be used and be given reliable data

Mr. Loveland discusses that the FDA needs reliable data, and not sloppy data. He also states that Aventis knew to contact the FDA and did not.
Listen